News Home

Do Analysts Agree Wednesday on Guardant Health Inc (GH) Stock's Target Price?

Wednesday, May 18, 2022 02:36 PM | InvestorsObserver Analysts
Do Analysts Agree Wednesday on Guardant Health Inc (GH) Stock's Target Price?

Wall Street is positive on Guardant Health Inc (GH). On average, analysts give GH a Strong Buy rating. The average price target is $121.5, which means analysts expect the stock to rise by 272.01% over the next twelve months. That average ranking earns GH an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by InvestorsObserver.

Overall Score - 4.8
Wall Street analysts are rating GH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GH!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Guardant Health Inc Stock Today?

Guardant Health Inc (GH) stock is trading at $32.66 as of 2:36 PM on Wednesday, May 18, a drop of -$1.81, or -5.25% from the previous closing price of $34.47. The stock has traded between $32.63 and $35.00 so far today. Volume today is below average. So far 868,116 shares have traded compared to average volume of 1,600,168 shares. Click Here to get the full Stock Report for Guardant Health Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App